Literature DB >> 16172610

ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf.

Y Dwivedi1, H S Rizavi, R R Conley, G N Pandey.   

Abstract

The Raf kinases Raf-1 and B-Raf are upstream activators of the extracellular signal-regulated kinase (ERK)-signaling pathway and therefore participates in many physiological functions in brain, including neuronal survival and synaptic plasticity. Previously, we observed that activation of ERK-1/2, the downstream component of ERK signaling, is significantly reduced in post-mortem brain of suicide victims. The present study was undertaken to further examine whether suicide brain is also associated with abnormalities in upstream molecules in ERK signaling. The study was performed in prefrontal cortex (PFC) and hippocampus obtained from 28 suicide victims and 21 normal controls. mRNA levels of Raf-1, B-Raf, and cyclophilin were measured by quantitative RT-PCR. Protein levels of Raf-1 and B-Raf were determined by Western blot, whereas their catalytic activities were determined by immunoprecipitation and enzymatic assays. It was observed that the catalytic activity of B-Raf was significantly reduced in PFC and hippocampus of suicide subjects. This decrease was associated with a decrease in its protein, but not mRNA, level. On the other hand, catalytic activity, and mRNA and protein levels, of Raf-1 were not altered in post-mortem brain of suicide subjects. The observed changes were not related to confounding variables; however, Raf-1 showed a negative correlation with age. Also, the changes in B-Raf were present in all suicide subjects, irrespective of psychiatric diagnosis. Our results of selective reduction in catalytic activity and expression of B-Raf but not Raf-1 suggest that B-Raf may be playing an important role in altered ERK signaling in brain of suicide subjects, and thus in the pathophysiology of suicide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16172610     DOI: 10.1038/sj.mp.4001744

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  50 in total

Review 1.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

2.  Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety.

Authors:  Soyong Jang; Donghyun Kim; Yeonju Lee; Sohyeon Moon; Seikwan Oh
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

3.  Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate.

Authors:  Thomas K Creson; Peixiong Yuan; Husseini K Manji; Guang Chen
Journal:  J Mol Neurosci       Date:  2008-08-03       Impact factor: 3.444

4.  Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression.

Authors:  Alejandro Orrico-Sanchez; Laetitia Chausset-Boissarie; Rodolphe Alves de Sousa; Basile Coutens; Sara Rezai Amin; Vincent Vialou; Franck Louis; Assia Hessani; Patrick M Dansette; Teodoro Zornoza; Carole Gruszczynski; Bruno Giros; Bruno P Guiard; Francine Acher; Nicolas Pietrancosta; Sophie Gautron
Journal:  Mol Psychiatry       Date:  2019-10-16       Impact factor: 15.992

5.  An association between the reduced levels of SLC1A2 and GAD1 in the dorsolateral prefrontal cortex in major depressive disorder: possible involvement of an attenuated RAF/MEK/ERK signaling pathway.

Authors:  Dong Hoon Oh; Daeyoung Oh; Hyeon Son; Maree J Webster; Cyndi S Weickert; Seok Hyeon Kim
Journal:  J Neural Transm (Vienna)       Date:  2014-03-22       Impact factor: 3.575

Review 6.  From synapse to nucleus: novel targets for treating depression.

Authors:  Herbert E Covington; Vincent Vialou; Eric J Nestler
Journal:  Neuropharmacology       Date:  2009-12-17       Impact factor: 5.250

7.  Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder.

Authors:  Bhaskar Roy; Michael Dunbar; Richard C Shelton; Yogesh Dwivedi
Journal:  Neuropsychopharmacology       Date:  2016-08-31       Impact factor: 7.853

Review 8.  MicroRNAs in depression and suicide: Recent insights and future perspectives.

Authors:  Yogesh Dwivedi
Journal:  J Affect Disord       Date:  2018-07-24       Impact factor: 4.839

9.  Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression.

Authors:  Adolfo Sequeira; Firoza Mamdani; Carl Ernst; Marquis P Vawter; William E Bunney; Veronique Lebel; Sonia Rehal; Tim Klempan; Alain Gratton; Chawki Benkelfat; Guy A Rouleau; Naguib Mechawar; Gustavo Turecki
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

10.  Brain-derived neurotrophic factor: role in depression and suicide.

Authors:  Yogesh Dwivedi
Journal:  Neuropsychiatr Dis Treat       Date:  2009-08-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.